vs
BIODESIX INC（BDSX）与Rumble Inc.（RUM）财务数据对比。点击上方公司名可切换其他公司
BIODESIX INC的季度营收约是Rumble Inc.的1.1倍（$28.8M vs $27.1M），BIODESIX INC净利率更高（-13.8% vs -120.8%，领先106.9%），BIODESIX INC同比增速更快（40.8% vs -10.5%），BIODESIX INC自由现金流更多（$692.0K vs $-31.7M），过去两年BIODESIX INC的营收复合增速更高（39.3% vs 15.2%）
BIODESIX INC是一家专注于肿瘤与感染病领域的分子诊断企业，开发并商业化创新血液检测解决方案，主要服务北美地区的医疗机构、生物制药合作伙伴及患者，核心业务包括辅助临床决策的个性化医疗产品。
Rumble Inc.是一家加美跨国企业，主营在线视频平台、网络托管及云服务，总部位于加拿大多伦多，美国总部设在佛罗里达州朗博特基。公司由加拿大科技创业者克里斯·帕夫洛夫斯基于2013年创立，云服务板块为Truth Social提供托管支持，其视频平台在美国保守派及极右翼用户群体中广受欢迎，属于“另类科技”阵营。
BDSX vs RUM — 直观对比
营收规模更大
BDSX
是对方的1.1倍
$27.1M
营收增速更快
BDSX
高出51.2%
-10.5%
净利率更高
BDSX
高出106.9%
-120.8%
自由现金流更多
BDSX
多$32.4M
$-31.7M
两年增速更快
BDSX
近两年复合增速
15.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $28.8M | $27.1M |
| 净利润 | $-4.0M | $-32.7M |
| 毛利率 | — | 5.5% |
| 营业利润率 | -6.8% | -131.1% |
| 净利率 | -13.8% | -120.8% |
| 营收同比 | 40.8% | -10.5% |
| 净利润同比 | 51.8% | 86.2% |
| 每股收益（稀释后） | $-3.35 | $-0.13 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BDSXRUM
| Q4 25 | $28.8M | $27.1M | ||
| Q3 25 | $21.8M | $24.8M | ||
| Q2 25 | $20.0M | — | ||
| Q1 25 | $18.0M | $23.7M | ||
| Q4 24 | $20.4M | $30.2M | ||
| Q3 24 | $18.2M | $25.1M | ||
| Q2 24 | $17.9M | $22.5M | ||
| Q1 24 | $14.8M | $17.7M |
净利润BDSXRUM
| Q4 25 | $-4.0M | $-32.7M | ||
| Q3 25 | $-8.7M | $-16.3M | ||
| Q2 25 | $-11.5M | — | ||
| Q1 25 | $-11.1M | $-2.7M | ||
| Q4 24 | $-8.3M | $-236.8M | ||
| Q3 24 | $-10.3M | $-31.5M | ||
| Q2 24 | $-10.8M | $-26.8M | ||
| Q1 24 | $-13.6M | $-43.3M |
毛利率BDSXRUM
| Q4 25 | — | 5.5% | ||
| Q3 25 | — | -1.8% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -26.7% | ||
| Q4 24 | — | -14.2% | ||
| Q3 24 | — | -45.4% | ||
| Q2 24 | — | -58.8% | ||
| Q1 24 | — | -79.5% |
营业利润率BDSXRUM
| Q4 25 | -6.8% | -131.1% | ||
| Q3 25 | -32.4% | -113.6% | ||
| Q2 25 | -48.6% | — | ||
| Q1 25 | -50.9% | -153.5% | ||
| Q4 24 | -32.5% | -80.1% | ||
| Q3 24 | -47.3% | -131.0% | ||
| Q2 24 | -46.0% | -172.7% | ||
| Q1 24 | -74.4% | -197.4% |
净利率BDSXRUM
| Q4 25 | -13.8% | -120.8% | ||
| Q3 25 | -40.0% | -65.7% | ||
| Q2 25 | -57.3% | — | ||
| Q1 25 | -61.8% | -11.2% | ||
| Q4 24 | -40.4% | -783.2% | ||
| Q3 24 | -56.5% | -125.9% | ||
| Q2 24 | -60.3% | -119.2% | ||
| Q1 24 | -91.9% | -244.1% |
每股收益（稀释后）BDSXRUM
| Q4 25 | $-3.35 | $-0.13 | ||
| Q3 25 | $-1.16 | $-0.06 | ||
| Q2 25 | $-0.08 | — | ||
| Q1 25 | $-0.08 | $-0.01 | ||
| Q4 24 | $-5.02 | $-1.17 | ||
| Q3 24 | $-1.40 | $-0.15 | ||
| Q2 24 | $-0.08 | $-0.13 | ||
| Q1 24 | $-0.14 | $-0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $19.0M | $237.9M |
| 总债务越低越好 | $50.0M | — |
| 股东权益账面价值 | $-2.5M | $274.8M |
| 总资产 | $87.5M | $336.8M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BDSXRUM
| Q4 25 | $19.0M | $237.9M | ||
| Q3 25 | $16.6M | $269.8M | ||
| Q2 25 | $20.7M | — | ||
| Q1 25 | $17.6M | $301.3M | ||
| Q4 24 | $26.2M | $114.0M | ||
| Q3 24 | $31.4M | $132.0M | ||
| Q2 24 | $42.2M | $154.2M | ||
| Q1 24 | $11.5M | $183.8M |
总债务BDSXRUM
| Q4 25 | $50.0M | — | ||
| Q3 25 | $50.0M | — | ||
| Q2 25 | $50.0M | — | ||
| Q1 25 | $40.0M | — | ||
| Q4 24 | $40.0M | — | ||
| Q3 24 | $40.0M | — | ||
| Q2 24 | $40.1M | — | ||
| Q1 24 | $40.1M | — |
股东权益BDSXRUM
| Q4 25 | $-2.5M | $274.8M | ||
| Q3 25 | $-1.7M | $302.2M | ||
| Q2 25 | $1.1M | — | ||
| Q1 25 | $11.1M | $339.6M | ||
| Q4 24 | $20.9M | $-63.1M | ||
| Q3 24 | $27.9M | $166.1M | ||
| Q2 24 | $36.3M | $192.7M | ||
| Q1 24 | $-5.5M | $210.7M |
总资产BDSXRUM
| Q4 25 | $87.5M | $336.8M | ||
| Q3 25 | $88.7M | $367.2M | ||
| Q2 25 | $87.7M | — | ||
| Q1 25 | $86.2M | $391.1M | ||
| Q4 24 | $97.2M | $195.3M | ||
| Q3 24 | $102.7M | $217.2M | ||
| Q2 24 | $115.8M | $243.2M | ||
| Q1 24 | $87.2M | $263.0M |
负债/权益比BDSXRUM
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 43.95× | — | ||
| Q1 25 | 3.62× | — | ||
| Q4 24 | 1.92× | — | ||
| Q3 24 | 1.44× | — | ||
| Q2 24 | 1.10× | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $778.0K | $-29.4M |
| 自由现金流经营现金流 - 资本支出 | $692.0K | $-31.7M |
| 自由现金流率自由现金流/营收 | 2.4% | -117.2% |
| 资本支出强度资本支出/营收 | 0.3% | 8.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-23.5M | $-70.8M |
8季度趋势，按日历期对齐
经营现金流BDSXRUM
| Q4 25 | $778.0K | $-29.4M | ||
| Q3 25 | $-8.9M | $-10.6M | ||
| Q2 25 | $-6.6M | — | ||
| Q1 25 | $-8.6M | $-14.5M | ||
| Q4 24 | $-4.1M | $-12.4M | ||
| Q3 24 | $-10.7M | $-19.1M | ||
| Q2 24 | $-18.6M | $-21.7M | ||
| Q1 24 | $-15.3M | $-33.9M |
自由现金流BDSXRUM
| Q4 25 | $692.0K | $-31.7M | ||
| Q3 25 | $-8.9M | $-12.0M | ||
| Q2 25 | $-6.6M | — | ||
| Q1 25 | $-8.7M | $-14.6M | ||
| Q4 24 | $-4.9M | $-12.4M | ||
| Q3 24 | $-10.9M | $-19.9M | ||
| Q2 24 | $-20.5M | $-23.1M | ||
| Q1 24 | $-15.5M | $-34.3M |
自由现金流率BDSXRUM
| Q4 25 | 2.4% | -117.2% | ||
| Q3 25 | -41.0% | -48.6% | ||
| Q2 25 | -33.1% | — | ||
| Q1 25 | -48.3% | -61.7% | ||
| Q4 24 | -24.2% | -40.9% | ||
| Q3 24 | -60.1% | -79.5% | ||
| Q2 24 | -114.3% | -102.8% | ||
| Q1 24 | -104.9% | -193.3% |
资本支出强度BDSXRUM
| Q4 25 | 0.3% | 8.5% | ||
| Q3 25 | 0.2% | 5.7% | ||
| Q2 25 | 0.3% | — | ||
| Q1 25 | 0.4% | 0.6% | ||
| Q4 24 | 4.1% | 0.1% | ||
| Q3 24 | 1.3% | 3.4% | ||
| Q2 24 | 10.7% | 6.1% | ||
| Q1 24 | 1.6% | 2.4% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BDSX
| Diagnostic Tests | $25.1M | 87% |
| Development Services | $3.6M | 13% |
RUM
| Audience Monetization | $23.8M | 88% |
| Other Initiatives | $3.3M | 12% |
